Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
180 JPY | -1.10% | +0.56% | -5.26% |
2023 | NANO MRNA, Kao Tie Up to Develop mRNA Therapies for Allergic Diseases | MT |
2023 | NANO MRNA Co., Ltd. and Kao Corporation Agree a Comprehensive Collaborative Research for mRNA Drug Discovery | CI |
Sales * | - | Sales 1 * | - | Capitalization | 16.83B 108M |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - 0 | Net cash position 1 * | - 0 | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | 17 |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 93.47% |
1 day | -1.10% | ||
1 week | +0.56% | ||
Current month | -0.55% | ||
1 month | -7.22% | ||
3 months | +0.56% | ||
6 months | -5.26% | ||
Current year | -5.26% |
Managers | Title | Age | Since |
---|---|---|---|
Shiro Akinaga
CEO | Chief Executive Officer | 67 | 20-05-31 |
Koji Fujimoto
DFI | Director of Finance/CFO | 51 | 02-10-31 |
Comptroller/Controller/Auditor | 61 | 14-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Satoru Iino
BRD | Director/Board Member | 58 | 12-02-29 |
Kazunori Kataoka
FOU | Founder | 73 | 96-06-13 |
Teruo Okano
FOU | Founder | 75 | 96-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 180 | -1.10% | 144 800 |
24-05-07 | 182 | +1.68% | 145,900 |
24-05-02 | 179 | 0.00% | 185,000 |
24-05-01 | 179 | -1.10% | 429,200 |
Delayed Quote Japan Exchange, May 08, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.26% | 82.92M | |
+10.44% | 107B | |
+0.82% | 106B | |
+8.12% | 23.47B | |
-13.89% | 21.9B | |
-6.17% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- 4571 Stock